ESPEROVAX

esperovax-logo

Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.

#People #Financial #Website #More

ESPEROVAX

Industry:
Biotechnology

Address:
Plymouth, Minnesota, United States

Country:
United States

Website Url:
http://www.esperovax.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx



Current Advisors List

david-peralta_image

David Peralta Board Advisor @ Esperovax
Advisor
2020-01-01

Current Employees Featured

roger-s-newton_image

Roger S. Newton
Roger S. Newton Founder and Chairman @ Esperovax
Founder and Chairman

david-ohagan_image

David O&s;Hagan
David O'Hagan Founder, President & CEO @ Esperovax
Founder, President & CEO
2018-11-01

savita-nikam_image

Savita Nikam
Savita Nikam Founder, Director Of Research and Chief Science Officer @ Esperovax
Founder, Director Of Research and Chief Science Officer
2019-01-01

Founder


david-ohagan_image

David O'Hagan

roger-s-newton_image

Roger S. Newton

savita-nikam_image

Savita Nikam

Investors List

tech-startup-stabilization-fund_image

Tech Startup Stabilization Fund

Tech Startup Stabilization Fund investment in Venture Round - Esperovax

Official Site Inspections

http://www.esperovax.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.42 K

  • Host name: 192-185-144-146.unifiedlayer.com
  • IP address: 192.185.144.146
  • Location: Houston United States
  • Latitude: 29.8284
  • Longitude: -95.4696
  • Metro Code: 618
  • Timezone: America/Chicago
  • Postal: 77092

Loading ...

More informations about "Esperovax"

Esperovax - Crunchbase Company Profile & Funding

Esperovax is a biotechnology company based in Plymouth, MI. Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.See details»

Esperovax Company Profile 2024: Valuation, Funding

Esperovax General Information Description. Developer a novel vaccine technology intended to deliver oral vaccines and therapeutics to patients. The company's platform leverages molecular-based technology to effectively target …See details»

Esperovax Company Profile: Overview and Full News Analysis

Esperovax's technology allows for large-scale production and distribution of shelf-stable vaccines at a fraction of the cost of traditional injection-based treatments. Esperovax's mission is to lead …See details»

ESPEROVAX, INC. Company Profile | Plymouth, MI | Competitors ...

Find company research, competitor information, contact details & financial data for ESPEROVAX, INC. of Plymouth, MI. Get the latest business insights from Dun & Bradstreet.See details»

Esperovax Appoints Dr. Robin Robinson as President and CEO

May 1, 2023 Esperovax Board Chairman Roger Newton commented: "The appointment of Dr. Robinson as CEO marks a notable milestone for Esperovax, an organization committed to …See details»

Esperovax Awarded Subcontract for Development of …

Dec 12, 2024 Esperovax, Inc., a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today that DynPort Vaccine Company LLC …See details»

Esperovax LLC Overview - Salary.com

Esperovax LLC Information BETA. Headquarters Address: 46701 Commerce Center Dr, Plymouth, Michigan. Phone Number: +1 2486671845. Revenue: $1 Million - $5 Million ... The …See details»

Esperovax - UM - Innovation Partnerships

Esperovax is a startup developing novel mRNA oral vaccines. Launch: 2023. Subscribe to Our Newsletter . 1600 Huron Pkwy, Building 520, 2nd Floor Ann Arbor, MI 48109-2590 734-763 …See details»

Esperovax Awarded Subcontract for Development of …

Dec 12, 2024 About Esperovax: Esperovax, Inc. is a private U.S.-based biotechnology company focused on developing next-generation oral RNA vaccine and therapeutic platforms and …See details»

Esperovax, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Esperovax, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, and 2 literature, Disease Domain:Infectious Diseases, Technology Platform:Prophylactic vaccine, …See details»

ESPEROVAX SIGNS EXCLUSIVE LICENSING AGREEMENT WITH THE …

Nov 30, 2022 Esperovax was founded in 2019 to advance development of its Egress RDâ„¢ oral mRNA platform, a transformative technology for delivering mRNA vaccines to the abundant …See details»

Esperovax Awarded Subcontract for Development of ... - BioSpace

PLYMOUTH, Mich., Dec. 12, 2024 /PRNewswire/ -- Esperovax, Inc., a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today …See details»

Medical Countermeasures | BARDA establishes four new …

Aug 26, 2020 Esperovax: Esperovax looks to become the global leader in oral tablet/capsule vaccinations for some of the world's deadliest treatable diseases by leveraging its new oral …See details»

Esperovax and Ginkgo Bioworks Announce Partnership to Develop …

Jan 5, 2023 Initial focus of partnership will aim to develop cancer therapeutics . PLYMOUTH, Mich. and BOSTON, Jan. 5, 2023 /PRNewswire/ -- Esperovax, an innovative developer of oral …See details»

Esperovax Awarded $1M for Development of an Oral COVID-19 …

Oct 3, 2023 About Esperovax: Esperovax was founded in 2019 to advance development of its Egress RDâ„¢ oral mRNA platform, a transformative technology for delivering mRNA vaccines …See details»

mRNA vaccine - ESPEROVAX - AdisInsight

03 Oct 2023 Esperovax plans preclinical studies for COVID-19 infections (Prevention) in USA ; 30 Nov 2022 Early research in COVID-19 infections (Prevention) in USA (PO) You need to be a …See details»

Esperovax - Drug Discovery World (DDW)

Jan 10, 2023 Esperovax and Ginkgo Bioworks have agreed a partnership to develop circular RNAs (circRNAs) for a variety of therapeutic applications. Initially, the companies will work to …See details»

Esperovax Awarded New Contract With BARDA - PR Newswire

Sep 23, 2020 Esperovax has developed a proprietary method for bioengineering probiotic yeast to deliver continuous and high concentrations of vaccine antigen in the gut. These antigens …See details»

Esperovax - Company Profile - Tracxn

Esperovax - Developer of an oral vaccine for infectious diseases. from 2 investors. Founded by David O'Hagan, Savita Nikam and 1 other in the year 2018. Esperovax has 145 competitors. …See details»

Esperovax and Ginkgo Bioworks Announce Partnership to Develop …

Jan 5, 2023 Esperovax was founded in 2018 to advance the development of its Egress RDâ„¢ oral vaccine platform, a transformative technology for delivering vaccines to the abundant …See details»

linkstock.net © 2022. All rights reserved